TRPM7 and glioblastoma: Moreover, carvacrol treatment inhibits the proliferation and migration of glioblastoma cells by inhibiting the TRPM7-mediated mitogen-activated protein kinase (MAPK) and PI3K/Akt signaling pathways [202].